TRBV20OR9-2 and neoplasm: As shown in Fig. 5, compared with the FITC-labeled BSA and LDP protein, the FITC-labeled CDR3-LDP was able to enhance the binding intensity with tumor cells; the attachment of a single CDR3 domain increased the binding of LDP with tumor cells.